Pneuma Respiratory, Inc. announced it raised $300,000 in an initial filing from an offering of $3.3 Million

Company

Location

About

Pneuma Respiratory is a biotechnology company pioneering the development of digital inhalation therapies. By combining advanced breath-actuated inhaler technology with digital health capabilities, Pneuma aims to revolutionize respiratory drug delivery and improve patient outcomes. Their innovative platform enhances precision in drug administration for conditions such as asthma and COPD, while also enabling real-time data collection and remote patient monitoring. Through cutting-edge science and a dedicated leadership team, Pneuma Respiratory is redefining how respiratory diseases are treated and managed.